| John Michael Desaloms, MD | |
|
8230 Walnut Hill Ln, Ste 220, Dallas, TX 75231-4482 | |
| (214) 750-3646 | |
| (214) 363-2351 |
| Full Name | John Michael Desaloms |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 32 Years |
| Location | 8230 Walnut Hill Ln, Dallas, Texas |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699761510 | NPI | - | NPPES |
| 043005001 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | J5562 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Hospital For Surgery | Addison, TX | Hospital |
| Baylor Scott & White Medical Center Plano | Plano, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dallas Neurosurgical Associates Pa | 1254386907 | 15 |
News Archive
In a study published this week in the Proceedings of the National Academy of Sciences, a University of Wisconsin-Madison research team pinpoints how immune abnormalities beneath the retina result in macular degeneration, a common condition that often causes blindness.
The interim report highlighted 2012/13 expenditure on hospital medicines was a staggering £6.5bn – an 11% increase over the previous year. Lord Carter believed there were greater savings to be had by managing the demand for products through better inventory management rather than price reductions and that a target of £500m – 1bn savings on the £9bn procurement spend was realistic.
Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.
Myriad Genetics, Inc. today said data that provides further clinical validation supporting its newest molecular diagnostic product, PROLARIS™, was recently presented at the 2010 Genitourinary Cancers Symposium in San Francisco. The abstract of the presentation entitled: "Cell Cycle Genes Predict Recurrence After Radical Prostatectomy" by Gregory P. Swanson, M.D., University of Texas Health Science Center San Antonio, and colleagues is now available on the American Society of Clinical Oncology's website, www.asco.org.
› Verified 9 days ago
| Entity Name | Dallas Neurosurgical Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083600951 PECOS PAC ID: 1254386907 Enrollment ID: O20050316000277 |
News Archive
In a study published this week in the Proceedings of the National Academy of Sciences, a University of Wisconsin-Madison research team pinpoints how immune abnormalities beneath the retina result in macular degeneration, a common condition that often causes blindness.
The interim report highlighted 2012/13 expenditure on hospital medicines was a staggering £6.5bn – an 11% increase over the previous year. Lord Carter believed there were greater savings to be had by managing the demand for products through better inventory management rather than price reductions and that a target of £500m – 1bn savings on the £9bn procurement spend was realistic.
Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.
Myriad Genetics, Inc. today said data that provides further clinical validation supporting its newest molecular diagnostic product, PROLARIS™, was recently presented at the 2010 Genitourinary Cancers Symposium in San Francisco. The abstract of the presentation entitled: "Cell Cycle Genes Predict Recurrence After Radical Prostatectomy" by Gregory P. Swanson, M.D., University of Texas Health Science Center San Antonio, and colleagues is now available on the American Society of Clinical Oncology's website, www.asco.org.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Michael Desaloms, MD 8230 Walnut Hill Ln, Ste 220, Dallas, TX 75231-4482 Ph: (214) 750-3646 | John Michael Desaloms, MD 8230 Walnut Hill Ln, Ste 220, Dallas, TX 75231-4482 Ph: (214) 750-3646 |
News Archive
In a study published this week in the Proceedings of the National Academy of Sciences, a University of Wisconsin-Madison research team pinpoints how immune abnormalities beneath the retina result in macular degeneration, a common condition that often causes blindness.
The interim report highlighted 2012/13 expenditure on hospital medicines was a staggering £6.5bn – an 11% increase over the previous year. Lord Carter believed there were greater savings to be had by managing the demand for products through better inventory management rather than price reductions and that a target of £500m – 1bn savings on the £9bn procurement spend was realistic.
Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.
Myriad Genetics, Inc. today said data that provides further clinical validation supporting its newest molecular diagnostic product, PROLARIS™, was recently presented at the 2010 Genitourinary Cancers Symposium in San Francisco. The abstract of the presentation entitled: "Cell Cycle Genes Predict Recurrence After Radical Prostatectomy" by Gregory P. Swanson, M.D., University of Texas Health Science Center San Antonio, and colleagues is now available on the American Society of Clinical Oncology's website, www.asco.org.
› Verified 9 days ago
Matthew Sun, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-9946 | |
Dr. Martin Lewis Lazar, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 7777 Forest Ln, Suite B420, Dallas, TX 75230 Phone: 972-566-6444 Fax: 972-566-6627 | |
Dr. Blake Arden Yarascavitch, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1935 Medical District Dr, Suite B-3200, Dallas, TX 75235 Phone: 214-456-6660 | |
Kalil G Abdullah, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5303 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2300 Fax: 214-648-2204 | |
James Ebot, DO Neurological Surgery Medicare: Medicare Enrolled Practice Location: 17218 Preston Rd Ste 2000, Dallas, TX 75252 Phone: 877-866-7123 | |
Dr. Charles Benjamin Newman, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1411 N Beckley Ave, Pav Iii Ste#152, Dallas, TX 75203 Phone: 214-948-2076 Fax: 214-948-9990 | |
Bruce Edward Mickey, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2300 Fax: 214-645-2301 |